Commentary on Jiang et al [0.03%]
对江等人研究的评论
Munaiba Ahmad
Munaiba Ahmad
The 14th Canadian Symposium on Hepatitis C Virus: From research breakthroughs to equitable health care for priority populations [0.03%]
第十四届加拿大丙型肝炎病毒研讨会：从研究突破到优先人群公平医疗保健
Daniel N Elakpa,David Lawton,Trinity H Tooley et al.
Daniel N Elakpa et al.
Background: The hepatitis C virus (HCV) affects approximately 214,000 Canadians. While the availability of safe, effective direct-acting antivirals (DAA) has led to decreased rates of chronic HCV infection and increased t...
Prevalence and severity of MASLD and fibrosis using transient elastography: A cross-sectional screening in Lower Mainland, British Columbia, Canada [0.03%]
加拿大不列颠哥伦比亚省低陆平原地区MASLD及其纤维化的患病率和严重程度——一项横断面筛查研究
Kai Zhu,Harjot Bedi,Daljeet Chahal et al.
Kai Zhu et al.
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading cause of liver disease worldwide. We aimed to assess the prevalence and severity of MASLD and fibrosis among asymptomatic individua...
Trends in hepatitis C care in Canada's provincial and territorial prisons from 2020 to 2024 [0.03%]
2020年至2024年加拿大省级和地区的监狱内丙型肝炎护理趋势
Obey Albaini,Frederique Laprise,Jennifer Anderson-Apopei et al.
Obey Albaini et al.
Background: National hepatitis C virus (HCV) elimination efforts are contingent on the provision of care in prisons. This study aimed to assess HCV care practices in Canada's provincial/territorial prisons in 2024, compar...
Anti-HBs testing should not be performed before 9 months of age in infants of mothers with hepatitis B infection who received hepatitis B immunoglobulin at birth [0.03%]
新生儿母亲为乙肝患者且孩子出生时已注射乙型肝肽免疫球蛋白，婴儿在九个月前不需要进行抗HBs检测
Halil Haldun Emiroglu,Melike Emiroglu
Halil Haldun Emiroglu
Drug-induced liver injury secondary to anakinra in a patient with systemic juvenile idiopathic arthritis-Case report and literature overview [0.03%]
一项以全身型幼年特发性关节炎患者为对象的关于阿那白滞素引起的药物性肝损伤的病例报告及文献综述
Samantha Mannala,Mohit Kehar,Leah Samson et al.
Samantha Mannala et al.
Background: Anakinra, an interleukin-1 receptor antagonist, is widely used to manage systemic juvenile idiopathic arthritis (sJIA) and related inflammatory conditions. While generally well tolerated, rare cases of drug-in...
Shirley Jiang,Jeanette Feizi Farivar,Brandon Chan et al.
Shirley Jiang et al.
Fulminant liver failure due to Epstein-Barr virus in immunodeficiency disorders [0.03%]
免疫缺陷患者的EB病毒感染导致的急性肝衰竭
Diana Coman,Julian Hercun,Daniel Corsilli et al.
Diana Coman et al.
Background: The majority of patients with Epstein-Barr virus (EBV)-associated hepatitis have a mild clinical course; most infections resolve spontaneously. However, in rare cases, or in patients with underlying immune def...
A hepatology hero rides off into the sunset: A tribute to Dr Gerald Minuk [0.03%]
肝病英雄绝尘而去——致杰拉尔德·明库博士
Eric M Yoshida,Kelly Kaita,Natasha Chandok
Eric M Yoshida
Barriers and facilitators to liver fibrosis screening: Perspectives and practices of Canadian primary care physicians [0.03%]
加拿大初级保健医生对肝纤维化筛查障碍及促进因素的看法和实践
Duy A Dinh,Michael Betel,Mark Swain et al.
Duy A Dinh et al.
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is highly prevalent, yet primary care physicians (PCPs) face barriers to identifying and referring high-risk individuals. We surveyed Canadian P...